Ads
    Related paper
  1. The role of metformin hydrochloride in complex therapy of disorders of carbohydrate metabolism in patients with paranoid schizophrenia treated with atypical antipsychotics
  2. Dynamics of Psychopathological Disorders in Patients with Paranoid Schizophrenia during Atypical Antipsychotic Drugs Therapy
  3. Substance Use in Schizophrenia: Efficacy of Atypical Antipsychotics
  4. DYNAMICS OF INDICATORS OF SOCIAL FUNCTIONING IN CASE OF METABOLIC SYNDROME IN PATIENTS WITH PARANOID SCHIZOPHRENIA ON THE BACKGROUND OF ATYPICAL NEUROLEPTIC AGENTS APPLICA-TION AND IMPROVEMENT OF COMORBIDITY
  5. CORRECTION OF CARBOHYD-RATE DISORDERS IN PATIENTS WITH PARANOID SCHIZO-PHRENIA, RECEIVING LONG-THERM THERAPY WITH NEUROLYPTICS BY METFORMIN GYDROCHLORIDE
  6. DETERMINATION OF GLYCATED HEMOGLOBIN (HBA1C) FOR EARLY DETECTION OF DISORDERS OF CARBOHYDRATE METABOLISM PATIENTS WITH HYPERTENSION
  7. PREVALENCE OF DISORDERS OF CARBOHYDRATE METABOLISM IN PATIENTS IN THE ACUTE PHASE OF MYOCARDIAL INFARCTION AND AFTER DISCHARGE FROM THE HOSPITAL
  8. Effectiveness and Tolerability (with focus on metabolic effects) of three atypical Antipsychotics in the treatment of schizophrenia- A 48 week observational study.
  9. Early diagnostics of carbohydrate metabolism disorders in comparison with other metabolic disorders among employees of internal affairs bodies suffering from hypertension
  10. SLEEP RESPIRATORY EVENTS IN PATIENTS WITH TYPE 1 DIABETES: ROLE OF COMPENSATION OF CARBOHYDRATE METABOLISM